Johnson & Johnson (JNJ) Short-term Investments (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Short-term Investments data on file, last reported at $363.0 million in Q1 2026.

• Quarterly Short-term Investments rose 18.24% year-over-year to $363.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $363.0 million (up 18.24% YoY) and the FY2025 annual result came in at $393.0 million, down 5.76% from the prior year.
• Short-term Investments retreated to $363.0 million in Q1 2026 per JNJ's latest filing, from $393.0 million in the prior quarter.
• The five-year high for Short-term Investments was $22.7 billion in Q4 2022, with the low at $303.0 million in Q2 2025.
• Average Short-term Investments over 5 years is $6.2 billion, with a median of $906.5 million recorded in 2023.
• Year-over-year, Short-term Investments jumped 96.69% in 2022 and tumbled 91.85% in 2024.
• Johnson & Johnson's Short-term Investments stood at $22.7 billion in 2022, then tumbled by 95.3% to $1.1 billion in 2023, then slumped by 60.96% to $417.0 million in 2024, then decreased by 5.76% to $393.0 million in 2025, then fell by 7.63% to $363.0 million in 2026.
• Business Quant data shows JNJ's Short-term Investments at $363.0 million in Q1 2026, $393.0 million in Q4 2025, and $331.0 million in Q3 2025.